Back to Trades
Lorrain Daniel S.
Chief Scientific OfficerCIK 0001861550
Largest Purchase
No open-market purchases in the recent filings.
Profile
- Filings
- 11
- Buy transactions
- 0
- Sell transactions
- 16
- Companies
- 1
- Active
- 2025–2026
Lorrain Daniel S., Chief Scientific Officer, has filed 11 SEC reports (2025–2026), all concentrated in Contineum Therapeutics, Inc. (CTNM), totaling $3.5M in disclosed volume. Weighing $0 bought versus $1.1M sold, the history is heavily weighted toward selling. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
11 loaded
| Jul 10 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $16.6K |
| Jul 2 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $594.6K |
| Jun 1 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $54.9K |
| May 1 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $54.7K |
| Apr 6 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $56.0K |
| Mar 2 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $62.6K |
| Feb 26 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $130.2K |
| Feb 20 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $1.6K |
| Jan 30 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Award | $2.4M |
| Jan 6 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $43.5K |
| Dec 30 | CTNM Contineum Therapeutics, Inc. | Lorrain Daniel S. | Chief Scientific Officer | Sell | $51.0K |
11 filings